The government agency in charge of examining new pharmaceuticals before they are sold on the market is the BPA, while the agency in charge of ruling on applications for recognition as a new pharmaceuticals company is the IDB.
我國主管新藥審查上市的政府機關是衛生署藥政處，而新藥公司的申請、核定，則是經濟部工業局的權責。